LDL-C exposure and atherosclerosis progression.
Congress Presentation
About the speaker
Professor Alberico Catapano
6 more presentations in this session
Introduction - PSCK9 inhibition: a new horizon in LDL-C management.
Speaker: Professor C. Cannon (Boston, US)
PCSK9 inhibition: the data today and tomorrow.
Speaker: Professor S. Nicholls (Melbourne, AU)
Identifying appropriate patients to treat: a case-based approach.
Speaker: Professor C. Cannon (Boston, US) Professor A. Catapano (Milan, IT) Professor S. Nicholls (Melbourne, AU) Doctor P. Ridker (Boston, US) Doctor J. Robinson (Iowa, US)
Access the full session
PSCK9 inhibition: a new horizon in LDL-C management
About the event
ESC 365 is supported by
